Lilly’s efsitora shows promise in Phase III type 2 diabetes trials
Eli Lilly and Company has revealed positive topline results from the Phase III clinical trials of once-weekly insulin efsitora alfa…
Eli Lilly and Company has revealed positive topline results from the Phase III clinical trials of once-weekly insulin efsitora alfa…
Amid the hype of weight loss pills, Allurion is pushing ahead with its swallowable balloon – with the company reporting…
The emergence of incretin-modulating therapies has transformed the way healthcare providers are tackling the obesity pandemic. With groundbreaking drugs such…
Yunovia has announced the approval of its investigational new drug (IND) application by the Ministry of Food and Drug Safety…
Palatin Technologies has dosed the first subjects in a Phase II clinical trial evaluating the co-administration of bremelanotide with tirzepatide…
Eli Lilly’s blockbuster drug Zepbound (tirzepatide) has been effective in preventing the development of type 2 diabetes (T2D) in patients…
Fractyl Health has reported positive results for its hydrothermal ablation device Revita, as the company looks to battle the booming…
Otsuka Pharmaceutical is looking to acquire US-based Jnana Therapeutics in a deal worth up to approximately $1.1bn. The Japanese company…
Diamyd Medical has announced that the independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase III DIAGNODE-3…
CinFina Pharma has commenced the Phase I multiple-ascending dose (MAD) clinical trial of CIN-110 to treat obesity. The placebo-controlled, randomised…